WDR81
protein-codingWD repeat domain 81, the group of WD repeat domain containing|BEACH domain containing |Protein phosphatase 1 regulatory subunits|Armadillo like helical domain containing
Gene summary
This gene encodes a multi-domain transmembrane protein which is predominantly expressed in the brain and is thought to play a role in endolysosomal trafficking. Mutations in this gene are associated with an autosomal recessive form of a syndrome exhibiting cerebellar ataxia, cognitive disability, and disequilibrium (CAMRQ2). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~22.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012430
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012430
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012430
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0054794
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to WDR81 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001163809.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 157 | 11 | 174 | ||
| missense | 4 | 416 | 37 | 457 | ||
| nonsense | 5 | 14 | 1 | 20 | ||
| start loss | 0 | |||||
| frameshift | 3 | 14 | 1 | 18 | ||
| splice donor/acceptor (+/-2bp) | 3 | 2 | 5 | |||
| Total | 8 | 35 | 426 | 194 | 11 | 674 |
Highest pathogenic variant AF is 0.0000305986
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001157281.1 | 10 | MANE Select | |
| Ensembl | ENSP00000386609.1 | 10 | MANE Select | |
| RefSeq | NP_001157145.1 | 10 | Standard | |
| RefSeq | NP_001157283.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- ubiquitin-dependent protein catabolic process
- mitochondrion organization
- negative regulation of phosphatase activity
- aggrephagy
- regulation of phosphatidylinositol 3-kinase activity
Molecular Function
- protein binding
- phosphatidylinositol 3-kinase regulator activity
- K63-linked polyubiquitin modification-dependent protein binding
Cellular Component
- autophagosome membrane
- mitochondrion
- lysosomal membrane
- endoplasmic reticulum membrane
- Golgi apparatus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000409644
- Coding exons
- 10
- Length
- 22077
- Individuals with no LoFs
- 125557
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 47
- Defined
- 125604
- p
- 0.000187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.11 | 1000 | 1.21e+3 | 0.829 | 0.0000799 | 12394 |
| Missense (PolyPhen) | 391 | 528.73 | 0.7395 | 5658 | ||
| Synonymous | 1.60 | 502 | 550 | 0.913 | 0.0000389 | 4227 |
| Loss of Function | 4.57 | 24 | 63.2 | 0.380 | 0.00000336 | 664 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00063 | 0.00062 | rare |
| Latino/Admixed American | 0.000093 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00050 | 0.00046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.000066 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome (PubMed:27126989). May also play a role in aggrephagy, the macroautophagic degradation of ubiquitinated protein aggregates. In this process, may regulate the interaction of SQSTM1 with ubiquitinated proteins and also recruit MAP1LC3C (PubMed:28404643). May also be involved in maintenance of normal mitochondrial structure and organization (By similarity). {ECO:0000250|UniProtKB:Q5ND34, ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:27126989, ECO:0000269|PubMed:28404643}.;
Intolerance Scores
- LoFtool
- 0.504
- RVIS EVS
- -1.76
- RVIS percentile EVS
- 2.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.985
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |